Naunyn Schmiedebergs Arch Pharmacol
March 2025
Gastric cancer (GC) is the result of a convoluted series of incidents that include host genetic susceptibility, Helicobacter pylori infection, and other external influences. The emergence of many hereditary and chromatin modifications in carcinogenic and tumor-inhibiting genes results in the disruption of several molecular networks, upsetting the balance between cell proliferation and apoptosis as well as the cell cycle. Important roles are played by members of the Toll-like receptor (TLR) family in both native and adaptive immunological reactions.
View Article and Find Full Text PDFBackground: Mpox, formerly known as monkeypox, is a re-emerging viral disease. Vaccine acceptance is crucial for preventing its spread. This systematic review and meta-analysis assessed the acceptance of the Mpox vaccine among student populations.
View Article and Find Full Text PDFIntroduction: Falls are a significant health concern among older adults, particularly those with cancer, due to aging-related frailty, treatment-related adverse effects, and comorbidities. Existing reviews have highlighted the burden of falls in this population; however, the absence of a comprehensive meta-analysis to synthesize pooled results from relevant studies has limited the generalizability of their findings. This systematic review and meta-analysis aimed to estimate the global prevalence of falls among older adults with cancer and provide evidence to guide prevention efforts.
View Article and Find Full Text PDFBackground: Recent outbreaks of monkeypox (Mpox) have raised concerns about its complications, including ophthalmic manifestations such as conjunctivitis, keratitis, and potential vision impairment. The lack of comprehensive data on these ocular complications hinders the development of effective clinical guidelines. This review aim to synthesize existing evidence on the prevalence and characteristics of Mpox-related ocular complications.
View Article and Find Full Text PDFBackground: Chronic obstructive pulmonary disease (COPD) significantly impacts global health due to persistent airflow limitation and inflammation. Despite standard therapies, symptoms persist. Ensifentrine, targeting both bronchoconstriction and inflammation as a dual phosphodiesterase 3 and 4 inhibitor, offers a promising therapeutic advancement for COPD management.
View Article and Find Full Text PDF